Market Overview:
The global morphogenetic protein market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing use of morphogenetic proteins in various applications such as hospitals, medical centers, and laboratories. Additionally, the growing demand for these proteins from emerging economies is also contributing to the growth of this market. However, factors such as high cost and limited availability are restraining the growth of this market. On the basis of type, BMP-1 accounted for a major share of the global morphogenetic protein market in 2017. This segment is expected to grow at a CAGR of 7% during the forecast period from 2018 to 2030 owing to its wide range of applications across different industries.
Product Definition:
Morphogenetic proteins (MPs) are proteins that play a role in the development and patterning of tissues and organs. They are important for organizing cells into specific patterns during embryonic development, and can also help maintain tissue organization in adults. MPs can be secreted by cells or localized within the cell cytoplasm.
BMP-1:
BMP-1, also known as Morphogenetic Protein is a member of the transforming growth factor family. It is naturally produced by the body and can be administered through injections or orally. BMP-1 has wide applications in orthopedics, neurosurgery & spine surgery, cardiovascular surgery and soft tissue repair procedures.
BMP-2:
BMP-2 (Morphogenetic Protein) is a member of the transforming growth factor family. It is naturally produced by the body and can be administered through injections or as an implant to help healing bones, cartilage, tendons & ligaments in patients with arthritis. BMP-2 has also been shown to stimulate bone formation when injected into joints that are damaged due to osteoarthritis.
Application Insights:
The market is segmented by application into hospital, medical center, and laboratory. The hospital segment dominated the market in 2017 owing to increasing government initiatives for developing healthcare infrastructure at a global level. For instance, in 2015 the World Health Organization (WHO) launched a plan to develop 100 new hospitals around the world by 2020 at a cost of USD 300 million each. As of 2018, 60 have been completed and another 40 are under construction or planning stages.
Medical centers are expected to be one of the fastest-growing segments during the forecast period due to increasing demand for minimally invasive surgeries with high precision equipment such as robot-assisted surgery systems and telemedicine devices that assist doctors remotely in diagnosing diseases or delivering treatment options through video conferences with patients living far from medical centers that offer advanced healthcare facilities.
Regional Analysis:
North America dominated the market in 2017 owing to the presence of a large number of Morphogenetic Protein (MP) manufacturers and suppliers. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities for development of novel products. In addition, high healthcare expenditure and favorable reimbursement policies are also contributing towards growth in this region.
Asia Pacific is anticipated to be one of the fastest-growing regions during the forecast period owing to rising medical tourism, improving healthcare infrastructure, growing awareness about various advanced treatments & therapies among patients & physicians, and availability of low-cost treatment options in this region. These factors are driving regional market growth positively.
Growth Factors:
- Increasing research and development expenditure by pharmaceutical and biotechnology companies for the discovery of novel therapeutics is expected to drive the growth of the morphogenetic protein market.
- The increasing use of morphogenetic proteins in regenerative medicine is another key factor that is expected to fuel the growth of this market in the coming years.
- Rising demand for stem cell therapies is also anticipated to boost demand for morphogenetic proteins during the forecast period.
- Growing awareness about regenerative medicine among healthcare professionals and patients is also projected to propel market growth in future years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Morphogenetic Protein Market Research Report
By Type
BMP-1, BMP-2
By Application
Hospital, Medical Center, Laboratory
By Companies
Zimmer Biomet, Bioventus, Stryker, Orthofix Holdings, DJO Global, Ossatec Benelux, Elizur
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
235
Number of Tables & Figures
165
Customization Available
Yes, the report can be customized as per your need.
Global Morphogenetic Protein Market Report Segments:
The global Morphogenetic Protein market is segmented on the basis of:
Types
BMP-1, BMP-2
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Medical Center, Laboratory
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Zimmer Biomet
- Bioventus
- Stryker
- Orthofix Holdings
- DJO Global
- Ossatec Benelux
- Elizur
Highlights of The Morphogenetic Protein Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- BMP-1
- BMP-2
- By Application:
- Hospital
- Medical Center
- Laboratory
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Morphogenetic Protein Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Morphogenetic proteins are proteins that play a role in morphogenesis, the process by which an organism changes its shape or form. Morphogenetic proteins can help to control the direction and speed of this transformation, as well as influencing other cellular processes.
Some of the major players in the morphogenetic protein market are Zimmer Biomet, Bioventus, Stryker, Orthofix Holdings, DJO Global, Ossatec Benelux, Elizur.
The morphogenetic protein market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Morphogenetic Protein Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Morphogenetic Protein Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Morphogenetic Protein Market - Supply Chain
4.5. Global Morphogenetic Protein Market Forecast
4.5.1. Morphogenetic Protein Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Morphogenetic Protein Market Size (000 Units) and Y-o-Y Growth
4.5.3. Morphogenetic Protein Market Absolute $ Opportunity
5. Global Morphogenetic Protein Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Morphogenetic Protein Market Size and Volume Forecast by Type
5.3.1. BMP-1
5.3.2. BMP-2
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Morphogenetic Protein Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Morphogenetic Protein Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Medical Center
6.3.3. Laboratory
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Morphogenetic Protein Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Morphogenetic Protein Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Morphogenetic Protein Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Morphogenetic Protein Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Morphogenetic Protein Demand Share Forecast, 2019-2026
9. North America Morphogenetic Protein Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Morphogenetic Protein Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Morphogenetic Protein Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Medical Center
9.4.3. Laboratory
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Morphogenetic Protein Market Size and Volume Forecast by Type
9.7.1. BMP-1
9.7.2. BMP-2
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Morphogenetic Protein Demand Share Forecast, 2019-2026
10. Latin America Morphogenetic Protein Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Morphogenetic Protein Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Morphogenetic Protein Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Medical Center
10.4.3. Laboratory
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Morphogenetic Protein Market Size and Volume Forecast by Type
10.7.1. BMP-1
10.7.2. BMP-2
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Morphogenetic Protein Demand Share Forecast, 2019-2026
11. Europe Morphogenetic Protein Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Morphogenetic Protein Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Morphogenetic Protein Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Medical Center
11.4.3. Laboratory
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Morphogenetic Protein Market Size and Volume Forecast by Type
11.7.1. BMP-1
11.7.2. BMP-2
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Marke Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Morphogenetic Protein Demand Share, 2019-2026
12. Asia Pacific Morphogenetic Protein Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Morphogenetic Protein Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Morphogenetic Protein Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Medical Center
12.4.3. Laboratory
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Morphogenetic Protein Market Size and Volume Forecast by Type
12.7.1. BMP-1
12.7.2. BMP-2
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Morphogenetic Protein Demand Share, 2019-2026
13. Middle East & Africa Morphogenetic Protein Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Morphogenetic Protein Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Morphogenetic Protein Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Medical Center
13.4.3. Laboratory
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Morphogenetic Protein Market Size and Volume Forecast by Type
13.7.1. BMP-1
13.7.2. BMP-2
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Morphogenetic Protein Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Morphogenetic Protein Market: Market Share Analysis
14.2. Morphogenetic Protein Distributors and Customers
14.3. Morphogenetic Protein Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Zimmer Biomet
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Bioventus
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Stryker
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Orthofix Holdings
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. DJO Global
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Ossatec Benelux
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Elizur
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
